Works matching IS 1175-3277 AND VI 23 AND IP 1 AND DT 2023
Results: 10
Safety and Tolerability of Tecarfarin (ATI-5923) in Healthy Chinese Volunteers: Multiple Oral Dose-Escalation Phase I Trial.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 101, doi. 10.1007/s40256-022-00562-5
- By:
- Publication type:
- Article
Challenges and Possible Solutions to Direct-Acting Oral Anticoagulants (DOACs) Dosing in Patients with Extreme Bodyweight and Renal Impairment.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 9, doi. 10.1007/s40256-022-00560-7
- By:
- Publication type:
- Article
Very Short Versus Longer Dual Antiplatelet Treatment After Coronary Interventions: A Systematic Review and Meta-analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 35, doi. 10.1007/s40256-022-00559-0
- By:
- Publication type:
- Article
A Real-World Matched Cohort Study of the Effect of Concomitant Amiodarone or Diltiazem Administration on Apixaban Peak and Trough Concentrations.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 59, doi. 10.1007/s40256-022-00556-3
- By:
- Publication type:
- Article
Statins Reduce Bleeding Risk in Patients Taking Oral Anticoagulants for Nonvalvular Atrial Fibrillation: A Retrospective Registry Study.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 89, doi. 10.1007/s40256-022-00555-4
- By:
- Publication type:
- Article
Antithrombotic Strategy in Secondary Prevention for High-Risk Patients with Previous Acute Coronary Syndrome: Overlap between the PEGASUS Eligibility and the COMPASS Eligibility in a Large Multicenter Registry.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 77, doi. 10.1007/s40256-022-00554-5
- By:
- Publication type:
- Article
Adherence and Discontinuation of Disease-Specific Therapies for Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 19, doi. 10.1007/s40256-022-00553-6
- By:
- Publication type:
- Article
Potential Cardiovascular Events Avoided with Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared with Ezetimibe Alone in Patients with Atherosclerotic Cardiovascular Disease Taking Maximally Tolerated Statins.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 67, doi. 10.1007/s40256-022-00552-7
- By:
- Publication type:
- Article
Novel Pulmonary Delivery of Drugs for the Management of Atrial Fibrillation.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 1, doi. 10.1007/s40256-022-00551-8
- By:
- Publication type:
- Article
Cost-Effectiveness of Adding Empagliflozin to Standard Treatment for Heart Failure with Preserved Ejection Fraction Patients in China.
- Published in:
- American Journal of Cardiovascular Drugs, 2023, v. 23, n. 1, p. 47, doi. 10.1007/s40256-022-00550-9
- By:
- Publication type:
- Article